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Crystal Structure of Bisphosphorylated IGF-1
Receptor Kinase: Insight into
Domain Movements upon Kinase Activation
ceptor autophosphorylation in the cytoplasmic portion
of the  chains, and it enhances the capability of the
kinase to phosphorylate downstream substrates [3]. Au-
tophosphorylation of Tyr1161, Tyr1165, and Tyr1166 in
the kinase activation loop is critical for kinase activity
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Vienna A-1121 abolishes mitogenic and transformation signaling [5]. In
IR, the conserved tyrosines Tyr972 and possibly Tyr984Austria
can become autophosphorylated [3] and serve as recog-
nition sites for the insulin receptor substrate IRS-1.
IGF-1R has been shown to play an important role inSummary
the development, growth, and survival of normal cells
[6, 7]. In cancer, activated IGF-1R has been implicatedBackground: The insulin-like growth-factor-1 (IGF-1)
in mitogenesis, transformation in vitro, and suppressionreceptor, which is widely expressed in cells that have
of apoptosis [8]. Elevated levels of IGF-1R have beenundergone oncogenic transformation, is emerging as a
detected in various tumors and are often associatednovel target in cancer therapy. IGF-1-induced receptor
with increased levels of circulating IGF-1 and/or IGF-2activation results in autophosphorylation of cytoplasmic
[9, 10]. Inhibition and downregulation of IGF-1R havekinase domains and enhances their capability to phos-
been shown to result in massive apoptosis of tumorphorylate downstream substrates. Structures of the ho-
cells in vivo, inhibition of tumorigenesis, and inductionmologous insulin receptor kinase (IRK) exist in an open,
of a host response leading to the eradication of survivingunphosphorylated form and a closed, trisphosphory-
tumor cells [11–15]. As a consequence, inhibition of tu-lated form.
mor signaling by blocking IGF-1R kinase activity is
thought to result in inhibition of tumor growth in vivoResults: We have determined the 2.1 A˚ crystal structure
[16].of the IGF-1 receptor protein tyrosine kinase domain
Crystal structures of the inactive IR kinase [17] (IRK)phosphorylated at two tyrosine residues within the acti-
and of the active trisphosphorylated IRK (IRK3P) com-vation loop (IGF-1RK2P) and bound to an ATP analog.
plexed to a substrate peptide [18] have delineated theThe ligand is not in a conformation compatible with
activation mechanism of this RTK family. Phosphoryla-phosphoryl transfer, and the activation loop is partially
tion of three conserved tyrosine residues within the acti-disordered. Compared to the homologous insulin recep-
vation loop promotes conformational changes that fi-tor kinase, IGF-1RK2P is trapped in a half-closed, pre-
nally allow ATP and protein substrates to access theviously unobserved conformation. Observed domain
active site. Although several other protein kinases weremovements can be dissected into two orthogonal rota-
also crystallized in their inactive, dephosphorylated andtional components.
in their fully active, phosphorylated forms [19, 20], less
is known about the structural intermediates along theConclusions: Conformational changes upon kinase ac-
activation pathway. The best-characterized example istivation are triggered by the degree of phosphorylation
probably the activation of CDK2 via cyclin binding andand are crucially dependent on the conformation of the
phosphorylation [21–23].proximal end of the kinase activation loop. This IGF-1RK
Here, we report the crystal structure of IGF-1RK in itsstructure will provide a molecular basis for the design of
bisphosphorylated form (IGF-1RK2P). A comparison toselective antioncogenic therapeutic agents.
the structures of inactive and fully active IRK allows
us to elucidate the conformational changes underlying
Introduction receptor activation. The resulting model will be applica-
ble for all IR family members. Furthermore, the IGF-
The type-1, insulin-like growth-factor receptor (IGF-1R) 1RK2P structure provides a basis for structure-guided
and insulin receptor (IR) are closely related members of inhibitor design.
the receptor tyrosine kinase (RTK) superfamily with their
highest homology residing in the tyrosine kinase do- Results and Discussion
main. IGF-1R, similar to IR, is composed of two  heter-
odimers [1]. The transmembrane  subunits contain cy- Protein Production and Phosphorylation Analysis
tosolic tyrosine kinase domains that are activated upon The tyrosine kinase domain (979–1286) of human IGF-
ligand (IGF-1, IGF-2, and insulin) binding to the two ex- 1R was expressed in a baculovirus/insect cell system.
tracellular  subunits [2]. IGF-1R activation leads to re-
Key words: cancer; crystal structure; growth-factor receptor; IGF-1;
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Analysis of the purified protein by electrospray mass 1083) folds into a twisted, five-stranded  sheet that is
flanked by helix C. The larger C-terminal lobe com-spectrometry revealed that the IGF-1RK, as isolated,
was in the unphosphorylated state. Before crystalliza- prises eight  helices and five short  strands. Similar to
other kinases, IGF-1RK2P contains several functionallytion, IGF-1RK was autophosphorylated in vitro with
MgATP. During the course of autophosphorylation, up important loop regions: the glycine-rich, phosphate
binding loop (1005–1012); the catalytic loop (1133–to six additional bands occurred progressively on native
PAGE gels, representing mono- to hexaphosphorylated 1142); and the activation loop (1152–1174), which con-
tains the three principal phosphorylation sites. The hingeforms. IGF-1RK2P became the major form after incuba-
tion for 30 min. Prolonged incubation resulted in a tran- region (1079–1085) connecting the N- and C-terminal
lobes is involved in adenine binding (see below). Thesient increase of higher phosphorylated forms (data not
shown). When incubation time is increased further, the overall structure of IGF-1RK2P most closely resembles
those of the highly homologous (84%) insulin receptorconcentration of the tris- to hexaphosphorylated spe-
cies decreased, and the bisphosphorylated protein ac- kinase (Figure 2c). It can be superimposed onto the
unliganded IRK with rmsd for all C atoms of 2.1 A˚ andcumulated. IGF-1RK2P was shown to be phosphory-
lated on Tyr1161 and Tyr1165 by peptide mapping of onto fully active IRK3P with rmsd of 1.4 A˚. The structural
similarity between the C-terminal domains is even moretryptic digests (data not shown). We also investigated
the pentaphosphorylated species, which was addition- striking. An alignment (Figure 3) of their C atoms results
in rmsd of 0.8 A˚ to IRK and 0.5 A˚ to IRK3P. Due toally phosphorylated on Tyr1166 and on two serine resi-
dues (Ser980 and Ser982). Ser980 is a cloning artifact, the high sequence homology as well as to structural
conservation, we expect that bisphosphorylated insulinbut the wild-type residue Tyr980 can presumably be-
come phosphorylated, too [5]. Our data and that of oth- receptor kinase [26] will assume the same conformation
as IGF-1RK2P.ers [24] indicate that IGF-1RK can become a dual-speci-
ficity kinase in vitro and practices a certain promiscuity
in autophosphorylation of its juxtamembrane residues.
Activation Loop Conformation
The phosphorylation of tyrosine, serine, or threonine
Structure Determination residues within the activation loop triggers conforma-
Crystallization trials with unphosphorylated protein only tional changes that finally lead to kinase activation. The
resulted in spherulite-like particles that did not diffract activation loop in its active, phosphorylated conforma-
X-rays. Initial crystallization conditions could be identi- tion is stabilized through the interaction of a phosphoryl
fied when ATP was used as an additive for screening. group and a cluster of basic residues on the opposite
Native gel electrophoresis of one crystal revealed that loop side [23, 27, 28]. In contrast, the activation loop in its
IGF-1RK had undergone autophosphorylation during unphosphorylated conformation lacks this transversal
crystallization and contained a mixture of bis- and tris- stabilization and consequently is often found poorly or-
phosphorylated species. Homogeneously bisphosphor- dered or disordered [29].
ylated IGF-1RK2P yielded diffraction quality crystals A superposition of IGF-1RK2P, IRK, and IRK3P based
(native-1, space group P3221) that were partially mer- on their C-terminal domains reveals that the most dra-
ohedrally twinned. The IGF-1RK2P structure was solved matic conformational changes occur in the activation
by a combination of SIR and MAD (Table 1) using two loop (Figures 3a and 4). The activation loops diverge
crystals with a negligible twinning fraction. The quality starting with Gly1152 (which precedes the invariant
of the initial electron density map was greatly enhanced 1153DFG motif) and converge again at Leu1173. In IGF-
through three-fold noncrystallographic symmetry (NCS) 1RK2P, the proximal end of the activation loop is stabi-
averaging (Figure 1). The refined structure was then used lized through main chain hydrogen bonds between
as a starting model for the refinement against data from Thr1157 and Lys1168. Additionally, Met1156 and Phe1154
a second, better-diffracting crystal form (native-2, space participate in a small hydrophobic cluster together with
group P32) obtained in the presence of magnesium. Both Phe1131 from the catalytic loop and Val1053, Met1054,
crystal forms feature a virtually identical noncrystallo- and Phe1057, which line one side of C. On its distal
graphic trimer. The native-2 structure will be used as side, the activation loop is stabilized through a short 
the reference model for discussion. The model includes sheet between 9 (1167–1169) and 6 (1130–1132),
three IGF-1RK2P molecules in the asymmetric unit (re- which precedes the catalytic loop. Interestingly, a similar
ferred to as molecules A, B, and C), each bound to the sheet is formed in IRK3P between 6 and a short 
nonhydrolyzable ATP analog, adenylyl-,-imido-diphos- strand (1155IRK–1156IRK) from the proximal end of thephate (AMP-PNP). The root-mean-square deviation activation loop.
(rmsd) between C atoms of individual monomers is on IGF-1RK has three phosphorylation sites in its activa-
average 0.43 A˚. tion loop: Tyr1161, Tyr1165, and Tyr1166. Two of them
(Tyr1161 and Tyr1165) are phosphorylated in IGF-1RK2P
as confirmed by mass spectroscopy, whereas Tyr1166Overview of the Structure
IGF-1RK2P displays the typical protein kinase fold (Fig- is not. Biochemical studies on the equivalent residues
in IRK (Tyr1158IRK, Tyr1162IRK, and Tyr1163IRK) have es-ure 2). It consists of two lobes linked by a single connec-
tion. ATP binding and catalysis take place in a deep tablished that autophosphorylation predominantly initi-
ates on Tyr1162IRK, immediately followed by phosphory-cleft between the two lobes. Secondary structure ele-
ments are designated according to the conventions lation of Tyr1158IRK [26]; this fits our data well. Contrasting
the well-ordered activation loop of IRK3P, its centraloriginally given for cAPK [25]. The N-terminal lobe (984–
IGF-1 Receptor Kinase Crystal Structure
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Table 1. Structure Determination and Refinement
Data Collectiona
Data Set Hg-1 Hg-2 Hg-3 Native-1 Native-2
Space group P3221 P3221 P3221 P3221 P32
Wavelength (A˚) 0.9000 1.0090 1.0000 1.5418 1.0500
Unit cell dimensions
a  b, c (A˚) 85.6, 271.7 85.6, 271.7 85.6, 271.7 85.7, 269.8 86.0, 132.2
Resolution (A˚) 30–2.7 30–2.7 30–2.7 20–2.8 20–2.1
Observed reflections 197,752 195,720 195,971 122,523 160,185
Unique reflections 30,972 31,019 31,071 27,669 63,650
Completeness (%) 94.3 (86.0) 94.6 (74.6) 94.9 (86.9) 95.0 (69.9) 99.3 (98.7)
Rsym (%)b 6.7 (27.0) 6.6 (27.8) 7.3 (27.1) 8.6 (21.6) 4.7 (44.0)
I/(I) 27.0 (7.0) 26.8 (5.4) 27.4 (7.1) 15.2 (5.9) 16.9 (2.3)
Phasing
Phasing power c
Dispersive acentrics — 1.27 0.72 1.22
Anomalous acentrics 1.97 2.22 1.87 —
Overall figure of merit 0.36/0.53
(centric/acentric)
Refinement of Native-2
Resolution (A˚) 20–2.1 Rms deviation
R factor d (%) 19.5 Bond length (A˚) 0.008
Free R factor d (%) 21.9 Bond angles () 1.8
Number of refined atoms 7,292 B factor along bonds (A˚2) 2.4
Average B factor (A˚2) 44.0 B factor along angles (A˚2) 3.7
a All data sets except native-1 were collected on beamline BW6 at DESY, Hamburg. Values in parentheses are for the highest resolution shell.
b Rsym  	hkl	i|Ii 
 I|/	hkl	iIi
c Phasing power  (FH/Lack of closure).
d R factor  	hkl||Fobs| 
 k|Fcalc||/	hkl|Fobs|; free R factor was calculated using 5% of data excluded from refinement.
part is disordered in IGF-1RK2P (1158–1164 and the served in IRK and the “closed” form of IRK3P (Figure
phosphotyrosyl side chain of pTyr1165). The only or- 3a). The tightening of the active site can be monitored
dered tyrosine (Tyr1166) points toward the solvent (Fig- through the C-C distance between residues Val1013
ure 4a) with its phenol group packed against the lipo- and Met1142, which flank the adenine ring (Figure 5).
philic part of the Lys1130 side chain. In IRK3P, the They are 14.4 A˚ apart in IGF-1RK2P, whereas the equiva-
equivalent Tyr1163IRK is found hydrogen bonded to lent residues in IRK and IRK3P (Val1010IRK and Met1039IRK)
Arg1155IRK (Figure 4b), thereby providing the crucial are separated by 15.0 and 12.8 A˚, respectively. The
transversal stabilization for the whole activation loop. domain movement from unphosphorylated to bisphos-
An equivalent arginine in IGF-1R (Arg1158) is disordered. phorylated kinase is obtained through a 19 rotation of
In IGF-1RK2P, the negative charge introduced by phos-  sheet and C (Figure 3b). The N- and C-terminal lobes
phorylation of Tyr1166 could be compensated through are roughly displaced as rigid bodies, parallel to each
its interaction with the guanidinium of Arg1158. The nec- other, resulting in 0.6 A˚ domain closure. The conver-
essary spatial change would order the activation loop sion to the catalytically active, trisphosphorylated spe-
to a more rigid conformation resembling that of the tris- cies induces an 11 rotation of the  sheet and an addi-
phosphorylated loop of IRK3P and thus trigger the lobe tional 37 rotation ofC. The movement is approximately
closure (see below) toward a fully active form. perpendicular to the first one (Figure 3a) with the result
of a more pronounced domain closure (1.6 A˚). An analy-
sis of the φ and  torsion angles identified fulcrums ofDomain Movements
both rotations in the hinge region and in the loop be-It is apparent that IGF-1RK2P is in an intermediate, “half-
closed” conformation between the “open” state ob- tween C and 4.
Figure 1. Structure Solution
Experimental electron density map around an
AMP-PNP molecule (native-1, see Experi-
mental Procedures) contoured at 1.2 . Su-
perimposed is the final atomic model. The
map was calculated at a resolution of 2.7 A˚
with purely experimental phases after density
modification. Carbon atoms are yellow, oxy-
gen atoms are red, nitrogen atoms are blue,
and phosphorous atoms are purple.
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Figure 2. Structure of IGF-1RK2P
(a) Ribbon diagram of an IGF-1RK2P monomer. The  helices are shown in red, and the  strands are in blue. The glycine-rich loop is colored
orange, the hinge region is magenta, the catalytic loop is green, and the activation loop is yellow. The bound ligand AMP-PNP is colored as
in Figure 1. Residues 1158–1164 (dashed lines) of the activation loop have no supporting electron density. The kinase insert connecting D
and E is disordered. For this figure and others, the kinase insert has been “grafted” from the native-1 structure (see Experimental Procedures)
onto the native-2 structure discussed in this paper.
(b) Stereo diagram showing the C trace of IGF-1RK2P. The orientation is the same as in (a). The chain is colored from red (residue 984) to
blue (residue 1286). The nucleotide is drawn in black.
(c) Sequence alignment between the kinase domains of IGF-1R and IRK. Secondary structure elements are indicated for IGF-1RK2P. Conserved
residues are shaded red. The sequences were taken from the SWISSPROT: IGF-1R, P08069; IR, P06213, numbering as in [17]. The alignment
was prepared with Clustal W [49] and ESPRIPT [50].
The downward movement of C toward the conforma- Gly1155 (both of which are conserved throughout the
protein kinases), and Met1156 of the activation looption observed in IRK3P is not possible in IGF-1R-2P
due to steric hinderance mainly by residues Phe1154, (Figure 4b). An activation-loop rearrangement upon
IGF-1 Receptor Kinase Crystal Structure
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The adenine ring is further packed between Ala1031
and Met1142. The ribose moiety forms a weak (3.2 A˚)
hydrogen bond between O3 and the carbonyl oxygen of
Leu1005. The - and -phosphate groups are hydrogen
bonded to the conserved Lys1033 and to Ser1009 of
the glycine-rich loop. The -phosphate group of AMP-
PNP is well separated (7.6 A˚) from O2 of the catalytic
Asp1135 (Asp1132IRK) [18, 30]; this separation is likely to
prevent accidental hydrolysis through a water molecule.
Differences in the binding mode of AMP-PNP in the
IRK3P structure can be analyzed in the context of a
pTyr1166-induced activation (Figure 5b). The lobe clo-
sure together with a rotation of the side chains from
Met1079 and Met1142 is matched by a rotation of the
AMP-PNP molecule, approximately 20 toward the
C-terminal lobe. The net result is, on average, a 1.7 A˚
downward translation of the adenine ring. The ribosyl
unit, upon following the movement, can form a hydrogen
bond to Asp1086 (Asp1083IRK) via its O2 hydroxyl group.
The ribose changes its conformation from C2-endo (in
IGF-1RK2P) to C3-endo (in IRK3P), probably to accom-
modate an improved hydrogen bonding pattern. An ac-
companying rotation around the phosphoglycosidic and
phosphate ester bonds displaces the -phosphate
group by 6 A˚ and brings it in position for phosphoryl
transfer. Thereby, catalytic loop residue Arg1139 (Arg1-
136IRK) is rotated such that its N can coordinate the
tyrosine phenolic oxygen of a peptidic substrate. The
ligand binding conformation of IGF-1RK2P is thus not
compatible with phosphoryl transfer.
The - and -phosphate groups of AMP-PNP in IRK3P
are stabilized through the coordination to two magne-
sium ions. Although IGF-1RK2P in the native-2 crystal
form was obtained in the presence of MgCl2, there was
only clear electron density for one bound Mg2 ion inFigure 3. Domain Movements upon Phosphorylation
one of the three monomers. The Mg2 ion is coordinated(a) Superposition based on the C-terminal lobes of IRK (red, activa-
by the - and -phosphates and two water molecules.tion loop in orange), IGF-1RK2P (green, activation loop in yellow),
and IRK3P (dark blue, activation loop in light blue). The three proteins Two further ligands required for an octahedrically coordi-
were aligned using all C atoms from the C-terminal domains except nated Mg2 ion were not observed. The presence of the
the conformationally distinct activation loop (1150–1172) and the cation is thus necessary to stabilize the catalytically
flexible loop between D and E (kinase insert, 1095–1105). The
active conformation of ATP, but not a mandatory prereq-rotation axes that align the  sheets of the N-terminal lobes with
uisite for ATP binding itself. Compared to IRK3P, theeach other are drawn in magenta (IRK onto IGF-1RK2P) and gray
(IGF-1RK2P onto IRK3P). AMP-PNP phosphate groups in IGF-1RK2P have rela-
(b) Superposition of the  sheets in the N-terminal lobes of IRK, tively high B factors (60–70 A˚2), indicating that the latter
IGF-1RK2P, and IRK3P. The color coding is as in Figure 3a; labels binding conformation is less rigid and probably less
indicate the N- and C-terminal ends of the N-terminal lobe.
stable.
All observed differences indicate that the ligand bind-
ing site can provide more space than apparent fromphosphorylation of Tyr1166 would abolish this block.
the fully active IRK3P structure alone. The situation isThe conserved Glu1050 could then make a 3.5 A˚ move-
somewhat reminiscent of the active site of fibroblastment toward Asp1153, bringing it into the vicinity of
growth factor receptor 1 kinase [31] (FGFR1K), which isprotein kinase conserved Lys1133. Additionally, the car-
also relatively open and accommodates an AMP-PCPboxyl of Asp1153 is pushed 5.5 A˚ farther to the bottom
molecule whose terminal phosphate is disordered. Theof the phosphate binding pocket. Glu1050 and Asp1153
availability of IGF-1RK2P with its relatively open activeare thus brought in place for proper Mg2 coordination.
site will be beneficial for soaking or cocrystallizing ex-The vacated space could be replenished by Val1053,
periments with new inhibitors that are too large to fit theMet1054, and the side chain of Met1079.
smaller IRK3P active site. An analysis of the sequence
conservation between IRK and IGF-1RK reveals oneActive Site and AMP-PNP Binding
area in the active site vicinity (Figure 5c) that will be ofThe nonhydrolyzable ATP analog AMP-PNP is tightly
special interest for drug design. Thr1083, Arg1084, andbound into the active site crevice (Figure 5). The N6 and
Glu1145 form a nonconserved surface patch at the sol-N1 nitrogen atoms are hydrogen bonded to the carbonyl
oxygen of Glu1080 and the amide nitrogen of Met1082. vent-exposed rim of the ATP binding pocket whereby
Structure
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Figure 4. Conformational Changes in the Activation Loop upon Phosphorylation
(a) Surface representation of IRK, IGF-1RK2P, and IRK3P. Residues comprising the activation loop (ribbon representation; color coding as in
Figure 3a) were omitted from the surface calculation. The AMP-PNP ligands are partly occluded through the N-terminal lobe. For IGF-1RK2P,
the N-terminal residues (Ala984–Glu990) of an NCS-related molecule are included, and for IRK3P the peptidic substrate [18] whose two
methionine residues contact the P1 and P3 pockets are included. Carbon atoms are green, oxygen atoms are red, nitrogen atoms are
blue, sulfur atoms are yellow, and phosphorous atoms are purple.
(b) Superposition of the IGF-1RK2P and IRK3P activation loops. Stereo view of the activation loops and selected parts of the N-terminal lobe.
The chain traces are colored as in Figure 3a; oxygen atoms are red, nitrogen atoms are blue, sulfur atoms are green, and phosphorous atoms
are purple. Carbon atoms are gray in IGF-1RK2P and light blue in IRK3P. Hydrogen bonds are marked as dotted lines. Blue labels refer to
IRK3P, and gray labels to IGF-1RK2P. For clarity, some residue labels were omitted.
respective side chain atoms are 7–12 A˚ apart from the face area, which is relatively large for a pure crystal
packing contact [32]. Its size is comparable to that ofadenine ring. It will be challenging to explore this region
with suitably designed inhibitors to provide compounds the dimer of phosphorylated ERK2 [33] which buries
1470 A˚2 and is likely to be functionally important [33,that are selective for IGF-1RK.
34]. At each protein-protein interface, residues from the
N-terminal tail (984–995) and the tip of helix C of oneProtein Substrate Association Sites
Phosphorylated IGF-1RK2P forms trimers in the crystals monomer contact residues of the activation loop and
parts of the substrate binding area of a second monomerused for this analysis (Figure 6). In both crystal forms,
the monomers are related by a proper three-fold NCS (Figures 4a and 6b). The binding mode of the N-terminal
residues in IGF-1RK2P crystals, however, is orthogonalaxis. Within the resulting trimer, only one type of contact
is observed. An individual interface buries 1380 A˚2 sur- to the peptide binding mode observed in the ternary
IGF-1 Receptor Kinase Crystal Structure
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Figure 6. The IGF-1RK2P NCS Trimer
(a) The trimeric assembly comprising the asymmetric unit is viewed
down the noncrystallographic three-fold axis. Individual protomers
A, B, and C are shown as a ribbon representation and color-coded
gray, yellow, and blue. The nucleotides are color-coded by atom
type: carbon is green, oxygen is red, nitrogen is blue, sulfur is yellow,
Figure 5. Active Center and AMP-PNP Binding and phosphorous is purple.
(b) The A-C interface. Molecule A is shown as a surface representa-(a) AMP-PNP interactions in the active site of IGF-1RK2P. The pro-
tion; residues within 4 A˚ distance to protomer C are colored green.tein is shown as a backbone representation (the glycine-rich loop
Molecule C is shown as a ribbon to highlight the surface complemen-is orange and transparent, the hinge region is magenta, the catalytic
tarity.loop is green, and the activation loop is light yellow). Atoms are
color coded by type: carbon is yellow, oxygen is red, nitrogen is
blue, sulfur is green, phosphorous is purple, and Mg2 is black.
Water molecules are blue-green spheres. Hydrogen bonds are IRK3P:AMP-PNP:peptide complex [18], and the activeshown as black dotted lines.
site itself is accessible to the solvent (Figure 4a). In(b) Superposition of the active sites of IGF-1RK2P (colored as in
IRK3P, the P1 and P3 pockets accommodate twoFigure 5a) and IRK3P (cyan and transparent) based on their
C-terminal domains. Atoms are color coded by type: carbon is yellow methionine side chains from the peptidic substrate. The
(IGF-1RK2P) and cyan (IRK3P), phosphorous is purple (IGF-1RK2P) pockets are formed by two shallow depressions which
and white (IRK3P), oxygen is red, nitrogen is blue, sulfur is green, are lined by mostly hydrophobic residues that are exclu-
and Mg2 is black. Hydrogen bonds are shown as dotted lines (IGF- sively conserved in IGF-1R. The general architecture of1RK2P, gray; IRK3P, cyan). Water molecules are omitted for clarity.
the P1 pocket is conserved in both structures, whereasLabels refer to the IGF-1R sequence, except for Asp1150IRK (cyan)
the P3 pocket is only partly formed due to the displace-in the activation loop of IRK3P.
(c) Sequence conservation between IRK and IGF-1RK mapped onto ment of the activation loop including Val1176, which
the active site surface. The color ramps from gray to orange with lines the P3 pocket (Figure 4b). In IGF-1RK2P, the P1
decreasing levels of conservation. The completely conserved, albeit pocket is free, and the P3 pocket is partly occupied
conformationally different, activation loop is colored green. by Pro988. Residues 1172–1174 of the activation loop
form a short  sheet with residues 985–987 from the N
Structure
962
terminus of the NCS-related molecule. Interestingly, a pated: (1) autophosphorylation of Tyr1165 and then
Tyr1161 introduces negative charges into the activationsimilar but spatially different interaction is observed in
IRK3P between the corresponding residues (1169IRK– loop that are compensated by (2) its change toward the
IGF-1RK2P conformation. (3) The active site is now free1171IRK) and the substrate peptide, which suggests that
those residues have the general role of a recognition for ligand (ATP) binding, but it is not in a conformation
for phosphoryl transfer. (4) Upon the phosphorylationsite for hydrogen bonding partners.
IGF-1RK can autophosphorylate in vitro whereby two of Tyr1166, the relatively flexible activation loop is or-
dered. (5) This establishes the P3 specificity pocketserine residues (Ser980 and Ser982) at the N-terminal
end of the kinase domain are found in the hyperphos- so that substrate binding can take place and triggers
the final lobe closure whereby ATP is moved toward thephorylated forms. In analogy to Tyr984IRK [3], another
putative phosphorylation site can be assigned to Tyr987 substrate tyrosine (or serine), enabling catalysis. Due to
the high level of sequence conservation and structural(Figure 4a). IRK displayed trans-phosphorylation [26],
suggesting this to be the likely mechanism for IGF-1RK, homology, the above scenario is likely to hold for all
insulin receptor family members.too. The present structure does not indicate a clear
mechanism for how Ser982 or Tyr987 could approach
the active site of the neighbor molecule for phosphoryla- Biological Implications
tion. This would require a rearrangement of both the N
terminus and the activation loop. In its present confor- The receptor tyrosine kinases play a pivotal role in
mation, the activation loop thus resembles the autoin- growth-factor signaling, but the broad clinical potential
hibitory conformation observed for the activation loop for their specific inhibition has only been realized within
of FGFR1K [31]. the last few years. Unlike other receptor tyrosine ki-
The extended interface does not promote oligomer nases, IGF-1R is not mutated in human tumor cells.
formation in solution, as deduced from its elution volume However, overexpression of IGF-1R and its growth fac-
in size-exclusion chromatography. Such conditions, tors are described for different human malignancies,
however, do not match the in vivo environment in the including tumors of the breast, colon, lung, prostate, and
periphery of a cytoplasmic membrane, where the whole pancreas. IGF-1R transmits an antiapoptotic survival
receptor exists as a dimer [1]. We conclude that the signal and proliferative stimuli to tumor cells. Conse-
large protein-protein interface does not directly suggest quently, its inactivation is hypothesized to inhibit tumor
a mechanism for the phosphorylation of N-terminal tyro- growth. To provide a starting point for structure-based
sine or serine residues. More experiments are needed inhibitor design, we have solved the crystal structure of
to elucidate whether the observed NCS trimer resembles the IGF-1R kinase domain in its half-activated, bispho-
a protein complex that is built during autophosphoryla- sphorylated form. A comparison to the structures of
tion. The relatively large size of the interface might reflect the homologous insulin receptor kinase in its inactive
a general property of this surface patch of the kinase (unphosphorylated) and fully active (trisphosphorylated)
domain that is optimized for protein-protein interaction. forms gives a detailed picture of the trigger mechanisms
and domain movements underlying receptor activation.
Full activation is precluded by the conformation of theConclusions
proximal end of the activation loop. A majority of the
The crystal structure of IGF-1RK2P provides us with the
currently known small-molecule kinase inhibitors target
structure of a receptor tyrosine kinase that is emerging
the ATP binding pocket, and we presume that this region
as an important new target in cancer therapy. Similar
will also be susceptible for potent inhibitors of IGF-1RK.
to the FGFR1K, it can accommodate its ligand in an
Besides providing a general description of the active
active site that is still relatively open. Such knowledge
site topology, the structure identifies a surface patch at
will be beneficial for the structure-based design and/or
the rim of the active site that is not conserved in IRK
improvement of novel drugs that target the kinase. The
and which could become a focus for selective inhibitors.
most striking difference to the homologous insulin re-
ceptor kinase structures is the conformation of the bis-
Experimental Proceduresphosphorylated activation loop, which stabilizes the
molecule in a half-closed overall conformation. To form Protein Expression and Purification
the fully active complex, the N-terminal lobe sequentially A vector encoding residues 979–1286 from the  chain of the human
IGF-1R fused to glutathione S-transferase (GST), and a thrombinperforms two perpendicular rotations, whose net result
cleavage site was created for expression in insect cells. The proteinis a closure of the active site cleft. The three observed
construct contained two mutations at the N terminus (E979G andstructures only provide snapshots of the kinase move-
Y980S) as a result of the gene fusion expression system employed.ment, but they present low-energy conformations of in-
High-titer viral stocks were generated in Spodoptera frugiperda (Sf9)
termediates in kinase activation and may help research- cells, and recombinant IGF-1RK was produced by infection of High
ers visualize [35] the amplitudes of the structural Five cells (Invitrogen) in serum-free medium. Cells were harvested
72 hr postinfection by centrifugation and lysed by freezing/thawingchanges during catalysis.
in 10 mM Tris-HCl (pH 8.0) supplemented with protease inhibitorsThe three tyrosine residues of the activation loop are
(Complete, Boehringer Mannheim).phosphorylated in a sequential order, which is likely
The IGF-1RK fusion protein was purified by ammonium sulfatedue to the spatial restrictions for an approaching trans-
precipitation followed by affinity chromatography on a glutathione
phosphorylating kinase [20]. Adding together the infor- Sepharose 4B column. GST was removed by cleavage with human
mation obtained from the structures of IRK, IGF-1RK2P,  thrombin (Enzyme Research Laboratories, 1 U/g for 1 hr at 37C),
followed by a second round of glutathione-affinity chromatography.and IRK3P, the following chain of events can be antici-
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The flowthrough was purified by ion-exchange chromatography on Structure Solution
Attempts to solve the structure by molecular replacement by usingMono-Q HR 10/10 (AmershamPharmacia). Traces of GST were re-
moved through an anti-GST affinity column prepared by coupling a several different models based on the coordinates of IRK or IRK3P
were not successful. Data from the multiwavelength experiment onpolyclonal goat anti-schistosomal glutathione S-transferase anti-
body (AmershamPharmacia) to Affi-Prep HZ hydrazide (BioRad). the mercury-substituted crystal were used together with a native
data set for the initial phasing. Anomalous as well as isomorphousHomogeneously bisphosphorylated protein (see below) was ob-
tained by chromatography on a Mono-Q column. Purity of phosphor- Patterson maps revealed three dominant sites in the asymmetric
unit of the IGF-1RK2P crystals. Phases were derived through aylated and unphosphorylated IGF-1RK preparations was assessed
by SDS-PAGE and reversed-phase chromatography on Bakerbond combination of MAD and SIR methods as implemented in SHARP
[38] where the native data set was treated as a derivative. The high-Wide-Pore C-18 (Baker). Protein (in 10 mM Tris-HCl [pH 8.0]) was
concentrated to 10 mg ml
1 and stored at 
20C. The observed energy remote data set Hg-3, because of its higher resolution and
better data quality, was treated as a pseudonative data set. Mapsmolecular weight from size exclusion analysis (Superdex 200, Amer-
shamPharmacia) was consistent with a monomer in solution. calculated in P3221 showed a clearer solvent boundary, as com-
pared to phasing in the enantiomorphic space group. Subsequent
density modification with SOLOMON revealed several  helices withIn Vitro Autophosphorylation
the correct handedness, confirming the space group. At this stage,Aliquots of IGF-1RK were phosphorylated in 20 mM Tris, 0.2 M NaCl
the electron density still contained many breaks and diffuse regions.(pH 7.8) by addition of MgCl2 and ATP to 25 mM and 7.5 mM,
To initiate three-fold NCS averaging, masks and transformation ma-respectively. The protein was incubated at 4C for 30 min, and the
trices between monomers were estimated by placing a model ofphosphorylation reaction was stopped by addition of an excess of
the phosphorylated insulin receptor kinase onto a skeletonized map.EDTA. The extent of phosphorylation was determined by polyacryl-
SHARP-derived phases as well as the averaging mask and initialamide gel electrophoresis on 10% native gels (Ready Gel, BioRad)
NCS operators were input to DM [39]. After 100 cycles of solventand mass spectrometry. Mass spectrometry was performed using
flattening, histogram matching, three-fold averaging, and iterativea PE Sciex (Thornhill, Ontario, Canada) API III triple-quadrupole
refinement of the transformation matrices, the resulting electronmass spectrometer equipped with a pneumatically assisted ion-
density was well traceable (Figure 1). The structure of IGF-1RK2P inspray source. Samples were dissolved in methanol/water containing
space group P32 was solved by molecular replacement with program0.1% formic acid and applied by injection mode. For peptide map-
AMoRe [40]. The refined structure of the noncrystallographic trimerping of the isoforms, RP HPLC purified protein was incubated with
in space group P3221 was used as the search model; water andtrypsin. Resulting peptides were desalted and subjected to mass
substrate molecules were omitted. A clear solution to the translationspectroscopy analysis using a Maldi Tof instrument (Voyager DE-
function emerged in space group P32.STR, PerSeptive Biosystems, Framingham, MA). Peptide samples
were prepared using dihydroxybenzoic acid as a matrix.
Refinement
Model building of the IGF-1RK2P structure was performed with OCrystallization
Crystals of IGF-1RK2P were produced by the hanging-drop vapor- [41]. The native-1 IGF-1RK2P structure was refined using REFMAC
[42] against detwinned structure factors. The initially strict NCSdiffusion method. Equal volumes (2l) of protein solution containing
2 mM AMP-PNP and 2 mM of reservoir solution [26%–30% PEG- restraints were loosened in subsequent cycles for residues that
featured large deviations from the mean position and showed strong5000 monomethylether, 200 mM (NH4)2SO4, and 100 mM HEPES
(pH 7.0)] were mixed and equilibrated at 4C. Bisphenoid shaped difference density in Fo 
 Fc maps. The model in space group P32
(native-2) was refined against the twinned data with CNS [43] usingcrystals (native-1, space group P3221) appeared after 3–4 weeks
and grew to an average size of 350  150  50 m3 (Table 1). The a least-squares residual that accounts for hemihedral twinning as
the target function. Water molecules were added by using CNS andspecific volume was 2.8 assuming three molecules in the asymmet-
ric unit, which corresponds to a solvent content of 59%. Later, a by inspection of Fo 
 Fc maps. The final model for native-2 (Table
1) includes 869 of the 921 residues in the asymmetric unit, threesecond crystallization condition (native-2, space group P32) was
established with 6 mM MgCl2, 2.0 M (NH4)2SO4, and 100 mM Tris molecules of the inhibitor AMP-PNP, one magnesium ion, three
sulfate ions, and 247 water molecules. In all three monomers, the first(pH 8.5) as the precipitant (Table 1).
five residues (979–983) and the tip of the activation loop (residues
1158–1164 and the side chain of Tyr1165) are disordered. Further-Data Collection
more, the loop between helices D and E, which comprises theFor cryogenic data collection, crystals were harvested into a stabiliz-
kinase insert region [44], is disordered (residues A1098–A1102,ing solution which contained glycerol (16% for native-1 and 30%
B1097–B1105, and C1098–C1102). However, in the native-1 model,for native-2) and flash frozen in a liquid N2 stream at 100 K. A first
the kinase insert had defined electron density in monomer A. Of thenative data set was collected on a rotating anode (Rigaku, RU200)
nonglycine, nonproline residues in the model, 91.6% have mainequipped with a MAR image plate. For the structure solution (Table
chain torsion angles in the most-favored Ramachandran regions,1), a derivative crystal was prepared by soaking native crystals for
and 8.4% are in additionally allowed regions [45]. Buried accessible70 hr in 0.1 mM methyl mercuric acetate dissolved in a reservoir
surface areas were calculated with CNS. Atomic superpositionssolution containing 32% PEG-5000 monomethylether. A MAD exper-
were calculated with FIT (G. Lu, personal communication). Calcula-iment on the mercury derivative was carried out at beamline BW6
tion of the local symmetry revealed a proper three-fold NCS. Itsof Desy, Hamburg. Diffraction data were collected at the inflection
axis is tilted by 10 with respect to the crystallographic c axis,point (  1.0090 A˚), the peak (  1.0000 A˚), and a high-energy
explaining in retrospect why no peak for a proper NCS axis wasremote wavelength (  0.9000 A˚) on a MAR-CCD detector. Data
found in the self-rotation function. Structure visualization was doneset native-2 was collected on the same beamline. Data were pro-
with MOLSCRIPT [46], RASTER3D [47], and InsightII (Molecular Sim-cessed with DENZO and SCALEPACK [36].
ulations).
Twinning
Intensity statistics [37] as well as a comparatively low Rsym for data Acknowledgments
merged in the hexagonal space groups indicated that the crystals
of native-1 are partially merohedrally twinned (twin operator –h,
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fraction allowed us to use two crystals that had only a very low Bartunik for beam time at BW6 at DESY-Hamburg; Margit Bauer
and Angela Schmid for help in data collection; Clemens Vonrheintwinning fraction of 0.03 and were not further detwinned for phasing
and structure solution. Native-2 crystals were twinned along a two- for discussions on MAD phasing; and Helmut Wittneben for provid-
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Accession Numbers
Atomic coordinates have been deposited in the Protein Data Bank
under accession code 1JQH.
Note added in proof
After this manuscript was finished, Till et al. [48] published the crystal
structure of an activation loop mutant of unphosphorylated IRK.
There, the activation loop is found disordered, and the kinase as-
sumes a half-closed conformation, enabling it to bind ATP, too.
